SUMA Technology and Newborn Screening Tests for Inherited Metabolic Diseases in Cuba: An Overview of the First 30 Years
Abstract The ultramicroanalytic system (SUMA), created in the 1980s, is a complete system of reagents and instrumentation to perform ultramicroassays combining the sensitivity of the micro-enzyme-linked immunosorbent assay (ELISA) tests with the use of ultramicrovolumes. This technology permitted establishing large-scale newborn screening programs (NSPs) for metabolic and endocrine disorders in Cuba. This article summarizes the main results of the implementation during the 30 years of SUMA technology in NSP for 5 inherited metabolic diseases, using ultramicroassays developed at the Department of Newborn Screening at the Immunoassay Center. Since 1986, SUMA technology has been used in the Cuban NSP for congenital hypothyroidism, initially studying thyroid hormone in cord serum samples. In 2000, a decentralized program for the detection of hyperphenylalaninemias using heel dried blood samples was initiated. These successful experiences permitted including protocols for screening congenital adrenal hyperplasia, galactosemia, and biotinidase deficiency in 2005. A program for the newborn screening of CH using the thyroid-stimulating hormone Neonatal ultramicro-ELISA was fully implemented in 2010. Nowadays, the NSP is supported by a network of 175 SUMA laboratories. After 30 years, more than 3.8 million Cuban newborns have been screened, and 1002 affected children have been detected. Moreover, SUMA technology has been presented in Latin America for over 2 decades and has contributed to screen around 17 million newborns. These results prove that developing countries can develop appropriate diagnostic technologies for making health care accessible to all.
Main Authors: | Reyes,Ernesto Carlos González, Castells,Elisa M., Frómeta,Amarilys, Arteaga,Ana Luisa, Río,Lesley Del, Tejeda,Yileidis, Pérez,Pedro L., Segura,Mary Triny, Almenares,Pedro, Perea,Yenitse, Carlos,Niurka M., Robaina,René, Fernández-Yero,José L. |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)
2016
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100313 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of newborn hearing screening program
by: Marinho,Ana Carolina Alves, et al.
Published: (2020) -
25 Years of Newborn Screening in Uruguay
by: Queijo,Cecilia, et al.
Published: (2021) -
Evaluation of the Genetic Screening Processor for the Performance of Newborn Screening Tests
by: Castro,Simone Martins de, et al.
Published: (2016) -
National newborn screening for sickle cell disease and communication of carrier status
by: Rocha,Diogo Fernandes da, et al.
Published: (2023) -
Scope and efficiency of the newborn screening program in identifying hemoglobin S
by: Ivo,Maria Lucia, et al.
Published: (2014)